(Q36025935)

11 August 2017

1 reference

title

Anti-inflammatory strategies in hypertension: focus on COX-1 and COX-2. (English)

1 reference

11 August 2017

Matthias Hermann

1

1 reference

11 August 2017

Frank Enseleit

series ordinal

2

1 reference

11 August 2017

Frank T Ruschitzka

series ordinal

3

1 reference

11 August 2017

publication date

1 February 2005

1 reference

Current Hypertension Reports

11 August 2017

published in

1 reference

11 August 2017

volume

7

1 reference

11 August 2017

issue

1

1 reference

11 August 2017

page(s)

52-60

1 reference

Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11906-005-0055-7

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-005-0055-7

Aspirin protects low density lipoprotein from oxidative modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-005-0055-7

Aspirin improves endothelial dysfunction in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-005-0055-7

Activation of endothelial L-arginine pathway in resistance arteries. Effect of age and hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-005-0055-7

Vasopeptidase inhibition exhibits endothelial protection in salt-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-005-0055-7

Nitric oxide inactivates endothelium-derived contracting factor in the rat aorta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-005-0055-7

Endogenous endothelin modulates blood pressure, plasma volume, and albumin escape after systemic nitric oxide blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-005-0055-7

State-of-the-Art lecture. Role of angiotensin and oxidative stress in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-005-0055-7

Nitric oxide synthase gene therapy rapidly reduces adhesion molecule expression and inflammatory cell infiltration in carotid arteries of cholesterol-fed rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-005-0055-7

Acute systemic inflammation impairs endothelium-dependent dilatation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-005-0055-7

A tale of two diseases: atherosclerosis and rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-005-0055-7

Generation of C-reactive protein and complement components in atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-005-0055-7

Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-005-0055-7

C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-005-0055-7

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-005-0055-7

Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-005-0055-7

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-005-0055-7

Molecular bases of the acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-005-0055-7

Aldosterone induces a vascular inflammatory phenotype in the rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-005-0055-7

Effect of bradykinin, TGF-beta1, IL-1beta, and hypoxia on COX-2 expression in pulmonary artery smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-005-0055-7

A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke

21 January 2018

1 reference

12 December 2020

In vitro Acetylation of Plasma Proteins, Enzymes and DNA by Aspirin

1 reference

12 December 2020

Prevention of inflammation-induced endothelial dysfunction: a novel vasculo-protective action of aspirin

1 reference

12 December 2020

Blood pressure increase and incidence of hypertension in relation to inflammation-sensitive plasma proteins

1 reference

12 December 2020

Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: A potential link between the renin-angiotensin system and atherosclerosis

1 reference

12 December 2020

Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Res

1 reference

12 December 2020

Celecoxib, a cyclooxygenase-2 inhibitor, reduces neointimal hyperplasia through inhibition of Akt signaling

1 reference

12 December 2020

Effects of chronic ETA-receptor blockade in angiotensin II-induced hypertension

1 reference

12 December 2020

The link among nitric oxide synthase activity, endothelial function, and aortic and ventricular hypertrophy in hypertension

1 reference

12 December 2020

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

1 reference

12 December 2020

Effects of aspirin on platelet-neutrophil interactions. Role of nitric oxide and endothelin-1

1 reference

12 December 2020

The liver as the site of C-reactive protein formation

1 reference

12 December 2020

Is C-reactive protein an independent risk factor for essential hypertension?

1 reference

12 December 2020

Impaired platelet-connective-tissue reaction in man after aspirin ingestion

1 reference

12 December 2020

Cyclooxygenase-2 is required for tumor necrosis factor-alpha- and angiotensin II-mediated proliferation of vascular smooth muscle cells

1 reference

12 December 2020

Structure and function of small arteries in salt-induced hypertension: effects of chronic endothelin-subtype-A-receptor blockade

1 reference

12 December 2020

The major receptor for C-reactive protein on leukocytes is fcgamma receptor II.

1 reference

12 December 2020

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

12 December 2020

Increased C-reactive protein concentrations in never-treated hypertension: the role of systolic and pulse pressures

1 reference

12 December 2020

Retinal vein occlusion: C-reactive protein and arterial hypertension

1 reference

12 December 2020

Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein

1 reference

12 December 2020

Circulating markers of inflammation for vascular risk prediction: are they ready for prime time

1 reference

12 December 2020

Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence

1 reference

12 December 2020

C-reactive protein and risks of future myocardial infarction and thrombotic stroke

1 reference

12 December 2020

Angiotensin II-induced leukocyte adhesion on human coronary endothelial cells is mediated by E-selectin

1 reference

12 December 2020

Interleukin-1 beta rapidly inhibits aortic endothelium-dependent relaxation by a DNA transcription-dependent mechanism.

1 reference

12 December 2020

Nitric oxide and vascular disease

1 reference

12 December 2020

Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart

1 reference

12 December 2020

Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis

1 reference

12 December 2020

Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension

1 reference

12 December 2020

Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib

1 reference

12 December 2020

A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis

1 reference

12 December 2020

Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study

1 reference

12 December 2020

Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac

1 reference

12 December 2020

Relation between C reactive protein concentrations and coronary microvascular endothelial function

1 reference

12 December 2020

Vasodilator dysfunction in aged spontaneously hypertensive rats: changes in NO synthase III and soluble guanylyl cyclase expression, and in superoxide anion production

1 reference

12 December 2020

Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptor-deficient mice

1 reference

12 December 2020

Upregulation of juxtaglomerular NOS1 and COX-2 precedes glomerulosclerosis in fawn-hooded hypertensive rats

1 reference

12 December 2020

Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults

1 reference

12 December 2020

Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries

1 reference

12 December 2020

Platelet-active drugs : the relationships among dose, effectiveness, and side effects

1 reference

12 December 2020

Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease

1 reference

12 December 2020

Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo

1 reference

12 December 2020

The risk of cardiovascular thrombotic events with selective cyclooxygenase-2 inhibitors

1 reference

12 December 2020

The kidney as a second site of human C-reactive protein formation in vivo

1 reference

12 December 2020

Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin

1 reference

12 December 2020

Short- and long-term COX-2 inhibition reverses endothelial dysfunction in patients with hypertension

1 reference

12 December 2020

Indomethacin and aspirin abolish prostaglandin release from the spleen

1 reference

12 December 2020

COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease

1 reference

12 December 2020

Cardiovascular mortality in patients with rheumatoid arthritis

1 reference

12 December 2020

Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide

1 reference

12 December 2020

Continuous release of vasodilator prostanoids contributes to regulation of resting forearm blood flow in humans

1 reference

12 December 2020

Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice

1 reference

12 December 2020

Inflammation and atherosclerosis

1 reference

12 December 2020

Selective COX-2 inhibition improves endothelial function in coronary artery disease

1 reference

12 December 2020

Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease

1 reference

12 December 2020

Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides

1 reference

12 December 2020

C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study

1 reference

12 December 2020

Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular diseases

1 reference

12 December 2020

Direct proinflammatory effect of C-reactive protein on human endothelial cells

1 reference

12 December 2020

Atherosclerosis — An Inflammatory Disease

1 reference

12 December 2020

Role of cyclooxygenase products in the regulation of vascular tone and in the endothelial vasodilator function of normal, hypertensive, and hypercholesterolemic humans

1 reference

12 December 2020

Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells

1 reference

12 December 2020

Association of high sensitivity C-reactive protein with coronary heart disease prediction, but not with carotid atherosclerosis, in patients with hypertension

1 reference

12 December 2020

Aspirin acetylates fibrinogen and enhances fibrinolysis. Fibrinolytic effect is independent of changes in plasminogen activator levels

1 reference

12 December 2020

Final report on the aspirin component of the ongoing Physicians' Health Study

1 reference

12 December 2020

Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis

1 reference

12 December 2020

Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study

1 reference

12 December 2020

Relationship between COX-2 specific inhibitors and hypertension

1 reference

12 December 2020

Risk of cardiovascular events associated with selective COX-2 inhibitors

1 reference

12 December 2020

Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study

1 reference

12 December 2020

Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue

1 reference

12 December 2020

C-reactive protein and the future risk of thromboembolic stroke in healthy men.

1 reference

12 December 2020

Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids

1 reference

12 December 2020

Inhibition of COX-2 prevents hypertension and proteinuria associated with a decrease of 8-iso-PGF2alpha formation in L-NAME-treated rats

1 reference

12 December 2020

Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease

1 reference

12 December 2020

Prothrombotic Consequences of the Oxidation of Fibrinogen and their Inhibition by Aspirin

1 reference

12 December 2020

Role of prostacyclin in the cardiovascular response to thromboxane A2

1 reference

12 December 2020

Experiences with aspirin (Acetylsalicylic acid) in the nonspecific prophylaxis of coronary thrombosis.

1 reference

12 December 2020

RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2

1 reference

12 December 2020

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

12 December 2020

In vitro antioxidant properties of potential biotransformation products of salicylate, sulphasalazine and amidopyrine

1 reference

12 December 2020

Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors

1 reference

12 December 2020

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

1 reference

12 December 2020

Effect of cyclooxygenase-2 inhibition with rofecoxib on endothelial dysfunction and inflammatory markers in patients with coronary artery disease

1 reference

12 December 2020

Blood pressure, C-reactive protein, and risk of future cardiovascular events

1 reference

12 December 2020

C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle

1 reference

12 December 2020

Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein

1 reference

12 December 2020

Oscillatory shear stress stimulates adhesion molecule expression in cultured human endothelium

1 reference

12 December 2020

Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis

1 reference

12 December 2020

The coxibs, selective inhibitors of cyclooxygenase-2.

1 reference

12 December 2020

Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease

1 reference

12 December 2020

Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology

1 reference

12 December 2020

Dual functionality of cyclooxygenase-2 as a regulator of tumor necrosis factor-mediated G1 shortening and nitric oxide-mediated inhibition of vascular smooth muscle cell proliferation

1 reference

12 December 2020

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

12 December 2020

Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly

1 reference

12 December 2020

Suppression of oxidative stress as a mechanism of reduction of hypercholesterolemic atherosclerosis by aspirin

1 reference

12 December 2020

Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats

1 reference

12 December 2020

10.1007/S11906-005-0055-7

Identifiers

DOI

1 reference

11 August 2017

1 reference